Company Filing History:
Years Active: 1996
Title: Wolfgang Frohlich: Innovator in Leukotriene Research
Introduction
Wolfgang Frohlich is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of leukotriene derivatives. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Wolfgang Frohlich holds a patent for "Leukotriene-B.sub.4 derivatives, process for their production and their applications." This patent highlights his expertise in creating compounds that can potentially lead to advancements in therapeutic treatments.
Career Highlights
Frohlich is associated with Schering Aktiengesellschaft, a prominent pharmaceutical company known for its research and development in innovative medical solutions. His role at the company has allowed him to focus on groundbreaking research that contributes to the understanding of leukotrienes.
Collaborations
Some of his notable coworkers include Werner Skuballa and Bernd Buchmann. Their collaborative efforts have further enhanced the research environment, fostering innovation and the development of new therapeutic strategies.
Conclusion
Wolfgang Frohlich's contributions to the field of leukotriene research exemplify the impact of dedicated inventors in advancing medical science. His work continues to inspire future innovations in healthcare.